| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 603434 | 72403 | KANOVA ADULTOS 6,75g SOLUCION RECTAL | KANOVA ADULTOS 6,75g SOLUCION RECTAL , 200 enemas | 5,4 ml | 37 | 200 | 14 | 200 enemas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72403/72403_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72403/72403_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2010-06-15 | 1 | 1 | 1 | 2010-06-15 | 2010-06-15 | 1 | 2011-05-27 | View Edit Delete | ||||||||||||
| 606051 | 34044 | DOLOCATIL CODEINA 500/15 mg COMPRIMIDOS | DOLOCATIL CODEINA 500/15 mg COMPRIMIDOS, 500 comprimidos | 500 mg/15 mg | 42 | 500 | 10 | 500 comprimidos | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/34044/34044_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/34044/34044_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 4115 | FERRER INTERNACIONAL S.A. | 1960-06-01 | 1 | 1 | 3 | 1960-06-01 | 2026-04-06 | 1 | 2014-11-13 | Lista III | View Edit Delete | |||||||||||
| 606733 | 80830 | TETRACAINA LAINCO 7,5 MG/G GEL | TETRACAINA LAINCO 7,5 MG/G GEL, 200 tubos de 6 g | 7,5 mg/g | 44 | 1200 | 21 | 200 tubos de 6 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80830/80830_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80830/80830_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2016-05-06 | 1 | 1 | 1 | 2016-05-07 | 2016-05-06 | 1 | 2017-11-17 | View Edit Delete | ||||||||||||
| 606734 | 80830 | TETRACAINA LAINCO 7,5 MG/G GEL | TETRACAINA LAINCO 7,5 MG/G GEL, 200 tubos de 25 g | 7,5 mg/g | 44 | 5000 | 21 | 200 tubos de 25 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80830/80830_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80830/80830_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1614 | LAINCO S.A. | 2016-05-06 | 1 | 1 | 1 | 2016-05-07 | 2016-05-06 | 1 | 2017-11-17 | View Edit Delete | ||||||||||||
| 603065 | 05330010 | ROTARIX SUSPENSION ORAL EN TUBO DOSIFICADOR. VACUNA ANTIRROTAVIRUS, VIVA | ROTARIX SUSPENSION ORAL EN TUBO DOSIFICADOR. VACUNA ANTIRROTAVIRUS, VIVA , 10 tubos dosificadores orales precargados de 1,5 ml | N/A (vacuna) | 44 | 10 | 17 | 10 tubos dosificadores orales precargados de 1,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05330010/05330010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05330010/05330010_p.pdf | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2689 | GLAXOSMITHKLINE S.A. | 2008-09-25 | 1 | 1 | 1 | 2008-09-25 | 2008-09-25 | 1 | 2024-02-20 | View Edit Delete | ||||||||||||
| 602507 | 64252 | THROMBOCID FORTE 5 mg/g POMADA | THROMBOCID FORTE 5 mg/g POMADA 100 tubos de 60 g | 5 mg/g | 44 | 6000 | 21 | 100 tubos de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64252/64252_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64252/64252_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 4840 | LACER S.A. | 2001-09-28 | 1 | 1 | 1 | 2001-09-28 | 2007-03-12 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 602509 | 32762 | THROMBOCID 1mg/g POMADA | THROMBOCID 1mg/g POMADA, 100 tubos de 60 g | 1 mg/g | 44 | 6000 | 21 | 100 tubos de 60 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/32762/32762_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/32762/32762_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 4840 | LACER S.A. | 1959-10-01 | 1 | 1 | 1 | 1959-10-01 | 2007-03-15 | 1 | 2011-10-14 | View Edit Delete | ||||||||||||
| 600259 | 66871 | OMEPRAZOL SERRACLINICS 40 mg POLVO PARA SOLUCION PARA PERFUSION EFG | OMEPRAZOL SERRACLINICS 40 mg POLVO PARA SOLUCION PARA PERFUSION EFG , 50 viales | 40 mg | 45 | 50 | 34 | 50 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66871/66871_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66871/66871_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2616 | LABORATORIOS SERRA PAMIES S.A. | 2005-06-06 | 1 | 1 | 1 | 2005-06-06 | 2005-06-06 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 606724 | 79593 | IBUPROFENO B. BRAUN 600 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | IBUPROFENO B. BRAUN 600 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 100 viales | 600 mg inyectable 6 ml | 45 | 100 | 34 | 100 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79593/79593_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79593/79593_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 306 | B BRAUN MEDICAL S.A. | 2015-03-03 | 1 | 1 | 1 | 2015-03-03 | 2016-03-03 | 1 | 2017-10-27 | View Edit Delete | ||||||||||||
| 606952 | 62953 | PROPOFOL LIPURO 10 mg/ml EMULSIÓN INYECTABLE Y PARA PERFUSIÓN | PROPOFOL LIPURO 10 mg/ml EMULSIÓN INYECTABLE Y PARA PERFUSIÓN, 10 viales de 100 ml | 10 mg/ml inyectable 100 ml | 45 | 10 | 34 | 10 viales de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62953/62953_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62953/62953_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 307 | B BRAUN MEDICAL S.A. | 2000-04-13 | 1 | 1 | 1 | 2000-04-13 | 2017-11-15 | 1 | 2018-11-07 | View Edit Delete | ||||||||||||
| 606953 | 62953 | PROPOFOL LIPURO 10 mg/ml EMULSIÓN INYECTABLE Y PARA PERFUSIÓN | PROPOFOL LIPURO 10 mg/ml EMULSIÓN INYECTABLE Y PARA PERFUSIÓN, 10 viales de 50 ml | 10 mg/ml inyectable 50 ml | 45 | 10 | 34 | 10 viales de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62953/62953_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62953/62953_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 307 | B BRAUN MEDICAL S.A. | 2000-04-13 | 1 | 1 | 1 | 2000-04-13 | 2017-11-15 | 1 | 2018-11-07 | View Edit Delete | ||||||||||||
| 605879 | 12767004 | NIMENRIX POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA | NIMENRIX POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE EN JERINGA PRECARGADA, 10 viales + 10 jeringas precargadas de disolvente | N/A (vacuna) | 45 | 10 | 34 | 10 viales + 10 jeringas precargadas de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/12767004/12767004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/12767004/12767004_p.pdf | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 29446 | PFIZER S.L. | 2012-05-28 | 1 | 1 | 1 | 2012-05-28 | 2012-05-28 | 1 | 2013-06-06 | View Edit Delete | ||||||||||||
| 600299 | 67021 | CEFAZOLINA SALA 2 G POLVO PARA SOLUCION INYECTABLE EFG | CEFAZOLINA SALA 2 G POLVO PARA SOLUCION INYECTABLE EFG, 50 viales | 2.000 mg | 45 | 50 | 34 | 50 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67021/67021_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67021/67021_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2005-09-05 | 1 | 1 | 1 | 2005-09-05 | 2005-09-05 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 600300 | 67022 | CEFAZOLINA SALA 1 G POLVO PARA SOLUCION INYECTABLE EFG | CEFAZOLINA SALA 1 G POLVO PARA SOLUCION INYECTABLE EFG, 100 viales | 1.000 mg | 45 | 100 | 34 | 100 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67022/67022_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67022/67022_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2005-09-06 | 1 | 1 | 1 | 2005-09-06 | 2005-09-06 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 600633 | 67871 | CEFTAZIDIMA SALA 1.000 mg POLVO PARA SOLUCION PARA PERFUSION EFG | CEFTAZIDIMA SALA 1.000 mg POLVO PARA SOLUCION PARA PERFUSION EFG , 50 viales | 1.000 mg | 45 | 50 | 34 | 50 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67871/67871_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67871/67871_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2006-06-13 | 1 | 1 | 1 | 2006-06-13 | 2006-06-13 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 600634 | 67872 | CEFTAZIDIMA SALA 2.000 mg POLVO PARA SOLUCION PARA PERFUSION EFG | CEFTAZIDIMA SALA 2.000 mg POLVO PARA SOLUCION PARA PERFUSION EFG , 50 viales | 2.000 mg | 45 | 50 | 34 | 50 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67872/67872_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67872/67872_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2006-06-13 | 1 | 1 | 1 | 2006-06-13 | 2006-06-13 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 600716 | 68080 | PIPERACILINA/TAZOBACTAM SALA 4/0.5 g POLVO PARA SOLUCION PARA PERFUSION EFG | PIPERACILINA/TAZOBACTAM SALA 4/0.5 g POLVO PARA SOLUCION PARA PERFUSION EFG , 50 viales | 4.000 mg/500 mg | 45 | 50 | 34 | 50 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68080/68080_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68080/68080_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2006-10-10 | 1 | 1 | 1 | 2006-10-10 | 2006-10-10 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 600717 | 68084 | PIPERACILINA/TAZOBACTAM SALA 2 g/0.25 g POLVO PARA SOLUCION PARA PERFUSION EFG | PIPERACILINA/TAZOBACTAM SALA 2 g/0.25 g POLVO PARA SOLUCION PARA PERFUSION EFG, 50 viales | 2.000 mg/250 mg | 45 | 50 | 34 | 50 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68084/68084_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68084/68084_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2006-10-10 | 1 | 1 | 1 | 2006-10-10 | 2006-10-10 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 602334 | 55418 | ANACLOSIL 500 mg polvo para solución inyectable y para perfusión | ANACLOSIL 500 mg polvo para solución inyectable y para perfusión, 100 viales | 500 mg | 45 | 100 | 34 | 100 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/55418/55418_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/55418/55418_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 1981-07-01 | 1 | 1 | 1 | 1981-07-01 | 1981-09-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 602342 | 55419 | ANACLOSIL 1000 mg polvo para solución inyectable y para perfusión | ANACLOSIL 1000 mg polvo para solución inyectable y para perfusión, 100 viales | 1.000 mg | 45 | 100 | 34 | 100 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/55419/55419_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/55419/55419_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 1981-07-01 | 1 | 1 | 1 | 1981-07-01 | 1981-09-01 | 0 | 2012-01-02 | View Edit Delete |
Page 18 of 1035, showing 20 records out of 20697 total, starting on record 341, ending on 360